Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 94965096 | 9496509 | 6 | F | 200708 | 20160727 | 20130904 | 20160802 | EXP | PHHY2012CA023738 | NOVARTIS | 48.14 | YR | M | Y | 0.00000 | 20160802 | CN | COUNTRY NOT SPECIFIED | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 94965096 | 9496509 | 1 | PS | SANDOSTATIN LAR DEPOT | OCTREOTIDE ACETATE | 1 | Intramuscular | 30 MG, QMO (EVERY 4 WEEKS) | U | 21008 | 30 | MG | /month |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 94965096 | 9496509 | 1 | Neuroendocrine carcinoma |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 94965096 | 9496509 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 94965096 | 9496509 | Asthenia | |
| 94965096 | 9496509 | Blood pressure increased | |
| 94965096 | 9496509 | Blood pressure systolic increased | |
| 94965096 | 9496509 | Body temperature decreased | |
| 94965096 | 9496509 | Gastrointestinal neoplasm | |
| 94965096 | 9496509 | Hepatic neoplasm | |
| 94965096 | 9496509 | Musculoskeletal pain |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |